Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nugent

Showing results (141-150 of 188) with videos related to

Pageof 19
Sort By:
The Annals of Thoracic Surgery|October 30, 2004
Cardiac surgery risk models: a position articleDavid M Shahian, Eugene H Blackstone, Fred H Edwards, et al.
Current Neuropharmacology|March 22, 2016
Therapeutic Modulation of Glutamate Receptors in Major Depressive DisorderBrittany A Jaso, Mark J Niciu, Nicolas D Iadarola, et al.
Archives of General Psychiatry|July 5, 2006
Reduced muscarinic type 2 receptor binding in subjects with bipolar disorderDara M Cannon, Richard E Carson, Allison C Nugent, et al.
Neuroimage|November 1, 2005
Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometryAllison C Nugent, Michael P Milham, Earle E Bain, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 26, 2013
Reduced post-synaptic serotonin type 1A receptor binding in bipolar depressionAllison C Nugent, Earle E Bain, Paul J Carlson, et al.
Revista De Psiquiatria Clinica|June 18, 2015
Biomarkers in mood disorders research: developing new and improved therapeuticsMark J Niciu, Daniel C Mathews, Dawn F Ionescu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 8, 2020
Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancerKonstantin H Dragnev, W Jeffrey Petty, Sumit J Shah, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 7, 2020
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 23, 1998
Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study GroupL J Dacey, J J Munoz, Y R Baribeau, et al.
Pageof 19

Showing results (141-150 of 188) with videos related to

Sort By:
Pageof 19
The Annals of Thoracic Surgery|October 30, 2004
Cardiac surgery risk models: a position articleDavid M Shahian, Eugene H Blackstone, Fred H Edwards, et al.
Current Neuropharmacology|March 22, 2016
Therapeutic Modulation of Glutamate Receptors in Major Depressive DisorderBrittany A Jaso, Mark J Niciu, Nicolas D Iadarola, et al.
Archives of General Psychiatry|July 5, 2006
Reduced muscarinic type 2 receptor binding in subjects with bipolar disorderDara M Cannon, Richard E Carson, Allison C Nugent, et al.
Neuroimage|November 1, 2005
Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometryAllison C Nugent, Michael P Milham, Earle E Bain, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 26, 2013
Reduced post-synaptic serotonin type 1A receptor binding in bipolar depressionAllison C Nugent, Earle E Bain, Paul J Carlson, et al.
Revista De Psiquiatria Clinica|June 18, 2015
Biomarkers in mood disorders research: developing new and improved therapeuticsMark J Niciu, Daniel C Mathews, Dawn F Ionescu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 8, 2020
Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancerKonstantin H Dragnev, W Jeffrey Petty, Sumit J Shah, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 7, 2020
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 23, 1998
Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study GroupL J Dacey, J J Munoz, Y R Baribeau, et al.
Pageof 19